£6,082
−17%vs Jun 2024Active12682575Private limited companyEly
RH PHARMA CONSULTING LTD
B76/10001
Summary
RH PHARMA CONSULTING LTD is an active private limited company (company number 12682575) incorporated on 19 June 2020, registered in Ely. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 June 2025, showing net assets of £6,082, with 1 employee on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 17% on the prior period (£7,345).
Peer position · net assets
By net assets it sits in the lower half of 196 comparable companies in Cambridge (median £15k, upper quartile £347k).
02
Key dates
- Incorporated
- 19 June 20206 yrs ago
- Next accounts due
- 30 March 2027in 159 days
- Confirmation statement due
- 3 July 2027in 254 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
03
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
04
Financials
Not reported
Not disclosed
1
No changevs Jun 2024| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | £6,082 | — | — | £624 | — | — | 1 |
| 30 June 2024 | £7,345 | — | — | £313 | — | — | 1 |
Current ratio10.87Comfortable
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
05
Firmoscan score
76 / 100 · grade B
| 50 | Starting scoreEvery scored company starts here |
| +10 | Positive net assetsNet assets £6,082 at 2025-06-30 |
| +8 | Comfortable liquidityCurrent ratio 10.87 |
| +8 | EstablishedIncorporated 2020-06-19 (6 years) |
| 76 | Score, grade B |
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice. How the score is computed.
06
Ownership and control
- Dr Richard John Hamlyn
- owns 75–100% of shares
- holds 75–100% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
07
Timeline
- Confirmation statement duein 254 days
- Next accounts duein 159 days
- Accounts period endNet assets £6,082 · micro accounts
- Accounts period endNet assets £7,345 · micro accounts
- Incorporated
08
Similar companies in Cambridge
- CELLRX LIMITEDCambridge · inc. Jun 2020
- KLURA LTDHaverhill · inc. Jun 2020
- ABBEXA LABORATORIES LTDCambridge · inc. Jun 2020
- SDS THERAPEUTICS LIMITEDCambridge · inc. Jul 2020
- TRANSITION BIO LIMITEDCambridge · inc. Jul 2020
- ZYGOSITY LIMITEDCambridge · inc. Jul 2020
All companies incorporated on 19 June 2020 · in Jun 2020.
09
Reminders for RH PHARMA CONSULTING LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.